OTCMKTS:FSNUY Fresenius SE & Co. KGaA (FSNUY) Stock Price, News & Analysis $9.38 +0.07 (+0.75%) (As of 10/9/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsHeadlinesShort Interest About Fresenius SE & Co. KGaA Stock (OTCMKTS:FSNUY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get FSNUY alerts:Sign Up Key Stats Today's Range$9.34▼$9.6150-Day Range$8.44▼$9.6152-Week Range$6.33▼$9.72Volume18,464 shsAverage Volume50,153 shsMarket Capitalization$20.96 billionP/E Ratio12.82Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewFresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.Read More… Bigger Than Nvidia? (Ad)Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that's all they'll talk about.Go here now for this breaking story. Receive FSNUY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address FSNUY Stock News HeadlinesFresenius looking to boost output after hurricane damage at rival BaxterOctober 9 at 5:05 AM | msn.comFresenius Kabi and Formycon Receive U.S. FDA Approval for Biosimilar Otulfi™* (ustekinumab-aauz)September 30, 2024 | finance.yahoo.comBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that's all they'll talk about.October 10, 2024 | InvestorPlace (Ad)Should You Investigate Fresenius SE & Co. KGaA (ETR:FRE) At €33.88?September 11, 2024 | finance.yahoo.comFresenius: Showing Signs Of Recovery, We Have DawnSeptember 9, 2024 | seekingalpha.comFresenius Sells IV Manufacturing Site In Chile To Medifarma; Terms Not DisclosedSeptember 2, 2024 | markets.businessinsider.comFresenius Kabi and AABB Announce Start of 19th Annual Blood Collectors Week September 1-7, 2024September 1, 2024 | finance.yahoo.comJinxin Fertility Group Limited (JXFGF)August 24, 2024 | uk.finance.yahoo.comSee More Headlines FSNUY Stock Analysis - Frequently Asked Questions How have FSNUY shares performed this year? Fresenius SE & Co. KGaA's stock was trading at $7.7250 at the beginning of the year. Since then, FSNUY shares have increased by 21.4% and is now trading at $9.38. View the best growth stocks for 2024 here. How were Fresenius SE & Co. KGaA's earnings last quarter? Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) issued its quarterly earnings results on Wednesday, July, 31st. The company reported $0.22 earnings per share for the quarter. The firm earned $5.83 billion during the quarter. How do I buy shares of Fresenius SE & Co. KGaA? Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Company Calendar Last Earnings7/31/2024Today10/10/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolOTCMKTS:FSNUY CUSIPN/A CIKN/A Webwww.fresenius.com Phone(496) 172-6080FaxN/AEmployees316,920Year Founded1912Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio12.82 Forward P/E Ratio11.44 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$24.01 billion Price / Sales0.87 Cash Flow$2.22 per share Price / Cash Flow4.22 Book Value$15.07 per share Price / Book0.62Miscellaneous Outstanding Shares2,234,009,000Free FloatN/AMarket Cap$20.96 billion OptionableNot Optionable Beta1.05 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report This page (OTCMKTS:FSNUY) was last updated on 10/10/2024 by MarketBeat.com Staff From Our PartnersPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredKamala’s tax plan is worse than you think—find out whyBuffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredNo matter the outcome of the election, it could be a death sentence for your wealth...In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional inv...Allegiance Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius SE & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius SE & Co. KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.